Advice About Eating Fish: For Women Who Are or Might Become Pregnant, Breastfeeding Mothers, and Young Children, From the Environmental Protection Agency and Food and Drug Administration; Revised Fish Advice; Availability, 32747-32749 [2019-14524]

Download as PDF 32747 Federal Register / Vol. 84, No. 131 / Tuesday, July 9, 2019 / Notices 2. Question #5: Additional evidencebased CDSME programs added to the list (reflective of approved programs included in the FY2019 Funding Opportunity Announcement). 3. Question #7: Information regarding funding source(s) requested to assess progress toward developing a sustainable program delivery infrastructure that is not solely reliant on ACL discretionary dollars. • Participant Information Survey: 1. Participant I.D. modified to reduce risk of personally identifiable information exposure. 2. Question #10: Added question regarding veteran status to further describe program participants, as well as to assist with partnerships with veteran-serving organizations. 3. Question #12: In tandem with Question #11, this item will allow for further assessment of caregiver status. 4. Question #14: Anxiety Disorder and Depression are listed separately (vs. being combined). Also included Yes/No response options for each chronic condition listed to improve data analyses and reporting. 5. Question #15: Response options have been delineated as sub-bullets (vs. being grouped into a single item) to align with the American Community Survey. 6. Question #16: Added question regarding social isolation, a construct Number of respondents Respondent/data collection activity Program facilitators (Program Information Cover Sheet, Attendance Log). Program participants (Participant Information Survey) ........... Data entry staff (Program Information Cover Sheet, Attendance Log, Participant Information Survey). Total ................................................................................. Dated: June 27, 2019. Mary Lazare, Principal Deputy Administrator. [FR Doc. 2019–14564 Filed 7–8–19; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–0595] Advice About Eating Fish: For Women Who Are or Might Become Pregnant, Breastfeeding Mothers, and Young Children, From the Environmental Protection Agency and Food and Drug Administration; Revised Fish Advice; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice of availability. The Food and Drug Administration (FDA or we) is announcing the availability of revised fish advice entitled ‘‘Advice About Eating Fish: For Women Who Are or Might Become Pregnant, Breastfeeding Mothers, and Young Children.’’ The revised advice updates advice that FDA and the U.S. Environmental Protection Agency (EPA) jointly issued in January 2017. The advice is intended to help women who are or might become pregnant, breastfeeding mothers, and parents of children over 2 years make khammond on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:47 Jul 08, 2019 Jkt 247001 Responses per respondent Annual burden hours Once per program ................. .33 445.5 13,500 65 1 ............................................. Once per program times 1,350 programs. .20 .17 2,700 229.5 ........................ ................................................ ........................ 3,375 Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or Frm 00049 Hours per response 1,350 informed choices about fish that are nutritious and safe to eat. We are revising the advice in accordance with a recent directive from Congress. FDA is seeking public comment on the development of educational materials on the updated fish advice for women who are or might become pregnant, breastfeeding mothers, and parents of young children. DATES: Although you can comment on the fish advice at any time, to ensure that FDA considers your comments on the development of educational materials before it begins work on such materials, submit either electronic or written comments on the requested information by September 9, 2019. ADDRESSES: You may submit comments as follows. PO 00000 which has been demonstrated to have an association with health-related risks for older adults. This question will also be asked upon completion of the last program session. 7. Question #17: This question will be asked at baseline and upon completion of the last program session to measure change. The proposed data collection tools may be found on the ACL website for review at https://www.acl.gov/aboutacl/public-input. Estimated Program Burden: ACL estimates the burden associated with this collection of information as follows: Fmt 4703 Sfmt 4703 confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2014–N–0595 for ‘‘Advice About Eating Fish: For Women Who Are or Might Become Pregnant, Breastfeeding Mothers, and Young Children.’’ Received comments will be placed in the docket and, except for those submitted as ‘‘Confidential E:\FR\FM\09JYN1.SGM 09JYN1 32748 Federal Register / Vol. 84, No. 131 / Tuesday, July 9, 2019 / Notices khammond on DSKBBV9HB2PROD with NOTICES Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ FDA will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/ blacked out, will be available for public viewing and posted on https:// www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.gpo.gov/ fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: William R. Jones, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240–402–1422, William.Jones@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of January 19, 2017 (82 FR 6571), FDA, in coordination with EPA, announced the availability of revised advice entitled ‘‘Advice About Eating Fish’’ (the ‘‘2017 advice’’). The 2017 advice encourages women who are pregnant and breastfeeding to consume VerDate Sep<11>2014 17:47 Jul 08, 2019 Jkt 247001 8 to 12 ounces of a variety of fish per week, from choices that are lower in mercury. The 2017 advice presents recommendations for how often the target audience should consume different fish, using a color-coded chart of more than 60 different fish. The chart presents fish in categories of ‘‘Best Choices,’’ from which we recommend the target audience eat a variety of 2 to 3 servings a week; ‘‘Good Choices,’’ from which we recommend the target audience eat 1 serving a week; and ‘‘Choices to Avoid.’’ On February 15, 2019, the Consolidated Appropriations Act, 2019 (Pub. L. 116–6) became law. Section 773 of Public Law 116–6 directs the Commissioner of Food and Drugs to, by July 1, 2019, and ‘‘following the review required under Executive Order 12866 (5 U.S.C. 601 note; relating to regulatory planning and review),’’ issue ‘‘advice revising the advice’’ provided in the notice of availability entitled ‘‘Advice About Eating Fish, From the Environmental Protection Agency and Food and Drug Administration, Revised Fish Advice, Availability’’ (82 FR 6571) in a manner that is ‘‘consistent with nutrition science recognized by FDA on the net effects of seafood consumption.’’ This notice announcing the availability of revised fish advice entitled ‘‘Advice About Eating Fish: For Women Who Are or Might Become Pregnant, Breastfeeding Mothers, and Young Children’’ responds to that directive. II. The Revised Fish Advice The revised fish advice, like the 2017 advice, is intended to encourage fish consumption by emphasizing the benefits of eating fish and to help women who are or might become pregnant, breastfeeding mothers, and parents of children over 2 years make informed choices among types of fish. Specifically, the revised advice, now renamed as ‘‘Advice About Eating Fish: For Women Who Are or Might Become Pregnant, Breastfeeding Mothers, and Young Children,’’ includes a statement that eating fish when pregnant or breastfeeding can provide health benefits and states that fish and other protein-rich foods have nutrients that can help children’s growth and development. The revisions also include a statement that, as part of a healthy eating pattern, eating fish may offer heart health benefits and lower the risk of obesity. The revised advice also makes clear that many types of fish are both nutritious and lower in mercury. The revised advice also discusses nutritional value of fish, as outlined in the 2015–2020 Dietary Guidelines for Americans. Based on information in the PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Dietary Guidelines, the revised advice states that fish are part of a healthy eating pattern and provide protein, healthy omega-3 fats (called docosahexaenoic acid and eicosapentaenoic acid), more vitamin B12 and vitamin D than any other type of food, iron, and other minerals like selenium, zinc, and iodine. Finally, the revised advice continues to provide information to help women who are or might become pregnant, breastfeeding mothers, and parents of children over 2 years choose varieties of fish that are lower in mercury. You may submit comments on the advice at any time. III. Consolidated Appropriations Act, 2019 The fish advice provides information for use by consumers. It is not intended to have the force and effect of law, does not implement, interpret, or prescribe law or policy, and does not describe procedural or practice requirements. As required by section 773 of Public Law 116–6, the revised advice was reviewed by the Office of Management and Budget under Executive Order 12866. The advice was revised in accordance with the directive in section 773 of Public Law 116–6 that the advice be updated ‘‘in a manner that is consistent with nutrition science recognized by FDA on the net effects of seafood consumption.’’ FDA considered the totality of the evidence, including nutrition science on the net effects of seafood consumption, when updating the fish advice. The overall changes we made include clarifying the target audience to make clear it applies to women who could become or are pregnant, women who are breastfeeding, and parents who are feeding children 2 years and older and adding highlights of key consumer messages, including that eating fish can provide health benefits when pregnant or breastfeeding, that many types of fish are both nutritious and lower in mercury, and that the consumption advice is based on mercury levels. Specifically, with respect to health benefits, the advice now highlights benefits related to risk of heart disease and obesity, benefits supporting children’s growth and development, and the substantive nutritional contributions to a healthy diet from protein, omega-3 fats, vitamin B12, vitamin D, iron, selenium, zinc, and iodine. The primary focus of the revisions is to further align the advice with the 2015–2020 Dietary Guidelines for Americans, which establishes Federal, evidence-based policy on diet and health. The revised advice supports the E:\FR\FM\09JYN1.SGM 09JYN1 Federal Register / Vol. 84, No. 131 / Tuesday, July 9, 2019 / Notices recommendations of the 2015–2020 Dietary Guidelines for Americans, developed for people 2 years and older, which reflects current science on nutrition to improve public health. The Dietary Guidelines for Americans focuses on dietary patterns and the effects of food and nutrient characteristics on health. FDA recognizes the nutrition science that is reflected in the guidelines, including nutrition science that was based on scientific analysis that considered evidence regarding the net effects of seafood consumption. In addition, the guidelines recommend eating fish as part of a healthy eating pattern because there are benefits in doing so. The process to develop the 2020–2025 Dietary Guidelines is under way, and per the Agricultural Act of 2014, will include a comprehensive review of scientific evidence and development of guidance for infants and toddlers from birth to 24 months, as well as for women who are pregnant. Additionally, EPA is in the process of updating its Integrated Risk Information System (IRIS) Assessment for Methylmercury. FDA will consider the final products from these efforts, as appropriate, in any future updates to the fish advice. khammond on DSKBBV9HB2PROD with NOTICES IV. Request for Comments FDA intends to develop educational materials such as simple factsheets, posters, infographics, and social media tool-kits on the updated fish advice for women who are or might become pregnant, breastfeeding mothers, and parents of young children. Specific materials will also be developed for health care professionals, health educators, nutritionists, and dietitians. These resources will be printable and could be used in physician’s offices, public health clinics, and stores. FDA is seeking public comment on: (1) Additional target populations that should be considered who may benefit from this advice; (2) Additional information that should be included in these educational resources; and (3) Additional effective means of disseminating and broadening the reach of this information. While FDA welcomes comment at any time, we would appreciate comments on these questions by September 9, 2019. V. Electronic Access Persons with access to the internet may obtain the advice at either https:// www.fda.gov/food/resources-you-food, or https://www.regulations.gov. Use the FDA website listed in the previous sentence to find the most current version of the advice. VerDate Sep<11>2014 17:47 Jul 08, 2019 Jkt 247001 Dated: July 2, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019–14524 Filed 7–8–19; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2019–N–2281] Incorporating Alternative Approaches in Clinical Investigations for New Animal Drugs; Public Meeting; Request for Comments AGENCY: Food and Drug Administration, HHS. Notice of public meeting; request for comment. ACTION: The Food and Drug Administration (FDA, the Agency, or we) is announcing a public meeting entitled ‘‘Incorporating Alternative Approaches in Clinical Investigations for New Animal Drugs.’’ This public meeting and request for comments is intended to support FDA guidance development as required by the Animal Drug and Animal Generic Drug User Fee Amendments of 2018. The topics to be discussed will inform the development of guidance to assist sponsors in incorporating complex adaptive and other novel investigation designs, data from foreign countries, real world evidence (including ongoing surveillance activities, observational studies, and registry data), biomarkers, and surrogate endpoints into proposed clinical investigation protocols and applications for new animal drugs under the Federal Food, Drug, and Cosmetic Act (FD&C Act). FDA is seeking comments from stakeholders, including representatives of regulated industry, consumer groups, academia, veterinarians, and food producers. DATES: The public meeting will be held on July 16, 2019, from 8:30 a.m. to 5 p.m. Submit either electronic or written comments on this public meeting by August 17, 2019. ADDRESSES: The public meeting will be held at Johns Hopkins University— Montgomery County, Gilchrist Hall, 9601 Medical Center Dr., Rockville, MD 20850. Free parking is available on site. You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before August 17, 2019. The https://www.regulations.gov electronic filing system will accept comments SUMMARY: PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 32749 until 11:59 p.m. Eastern Time at the end of August 17, 2019. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2019–N–2281 for ‘‘Incorporating Alternative Approaches in Clinical Investigations for New Animal Drugs.’’ Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 E:\FR\FM\09JYN1.SGM 09JYN1

Agencies

[Federal Register Volume 84, Number 131 (Tuesday, July 9, 2019)]
[Notices]
[Pages 32747-32749]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14524]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-0595]


Advice About Eating Fish: For Women Who Are or Might Become 
Pregnant, Breastfeeding Mothers, and Young Children, From the 
Environmental Protection Agency and Food and Drug Administration; 
Revised Fish Advice; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is announcing the 
availability of revised fish advice entitled ``Advice About Eating 
Fish: For Women Who Are or Might Become Pregnant, Breastfeeding 
Mothers, and Young Children.'' The revised advice updates advice that 
FDA and the U.S. Environmental Protection Agency (EPA) jointly issued 
in January 2017. The advice is intended to help women who are or might 
become pregnant, breastfeeding mothers, and parents of children over 2 
years make informed choices about fish that are nutritious and safe to 
eat. We are revising the advice in accordance with a recent directive 
from Congress. FDA is seeking public comment on the development of 
educational materials on the updated fish advice for women who are or 
might become pregnant, breastfeeding mothers, and parents of young 
children.

DATES: Although you can comment on the fish advice at any time, to 
ensure that FDA considers your comments on the development of 
educational materials before it begins work on such materials, submit 
either electronic or written comments on the requested information by 
September 9, 2019.

ADDRESSES: You may submit comments as follows.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to https://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2014-N-0595 for ``Advice About Eating Fish: For Women Who Are or 
Might Become Pregnant, Breastfeeding Mothers, and Young Children.'' 
Received comments will be placed in the docket and, except for those 
submitted as ``Confidential

[[Page 32748]]

Submissions,'' publicly viewable at https://www.regulations.gov or at 
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through 
Friday.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' FDA will review 
this copy, including the claimed confidential information, in its 
consideration of comments. The second copy, which will have the claimed 
confidential information redacted/blacked out, will be available for 
public viewing and posted on https://www.regulations.gov. Submit both 
copies to the Dockets Management Staff. If you do not wish your name 
and contact information to be made publicly available, you can provide 
this information on the cover sheet and not in the body of your 
comments and you must identify this information as ``confidential.'' 
Any information marked as ``confidential'' will not be disclosed except 
in accordance with 21 CFR 10.20 and other applicable disclosure law. 
For more information about FDA's posting of comments to public dockets, 
see 80 FR 56469, September 18, 2015, or access the information at: 
https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: William R. Jones, Center for Food 
Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus 
Dr., College Park, MD 20740, 240-402-1422, [email protected].

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of January 19, 2017 (82 FR 6571), FDA, in 
coordination with EPA, announced the availability of revised advice 
entitled ``Advice About Eating Fish'' (the ``2017 advice''). The 2017 
advice encourages women who are pregnant and breastfeeding to consume 8 
to 12 ounces of a variety of fish per week, from choices that are lower 
in mercury. The 2017 advice presents recommendations for how often the 
target audience should consume different fish, using a color-coded 
chart of more than 60 different fish. The chart presents fish in 
categories of ``Best Choices,'' from which we recommend the target 
audience eat a variety of 2 to 3 servings a week; ``Good Choices,'' 
from which we recommend the target audience eat 1 serving a week; and 
``Choices to Avoid.''
    On February 15, 2019, the Consolidated Appropriations Act, 2019 
(Pub. L. 116-6) became law. Section 773 of Public Law 116-6 directs the 
Commissioner of Food and Drugs to, by July 1, 2019, and ``following the 
review required under Executive Order 12866 (5 U.S.C. 601 note; 
relating to regulatory planning and review),'' issue ``advice revising 
the advice'' provided in the notice of availability entitled ``Advice 
About Eating Fish, From the Environmental Protection Agency and Food 
and Drug Administration, Revised Fish Advice, Availability'' (82 FR 
6571) in a manner that is ``consistent with nutrition science 
recognized by FDA on the net effects of seafood consumption.'' This 
notice announcing the availability of revised fish advice entitled 
``Advice About Eating Fish: For Women Who Are or Might Become Pregnant, 
Breastfeeding Mothers, and Young Children'' responds to that directive.

II. The Revised Fish Advice

    The revised fish advice, like the 2017 advice, is intended to 
encourage fish consumption by emphasizing the benefits of eating fish 
and to help women who are or might become pregnant, breastfeeding 
mothers, and parents of children over 2 years make informed choices 
among types of fish. Specifically, the revised advice, now renamed as 
``Advice About Eating Fish: For Women Who Are or Might Become Pregnant, 
Breastfeeding Mothers, and Young Children,'' includes a statement that 
eating fish when pregnant or breastfeeding can provide health benefits 
and states that fish and other protein-rich foods have nutrients that 
can help children's growth and development. The revisions also include 
a statement that, as part of a healthy eating pattern, eating fish may 
offer heart health benefits and lower the risk of obesity. The revised 
advice also makes clear that many types of fish are both nutritious and 
lower in mercury.
    The revised advice also discusses nutritional value of fish, as 
outlined in the 2015-2020 Dietary Guidelines for Americans. Based on 
information in the Dietary Guidelines, the revised advice states that 
fish are part of a healthy eating pattern and provide protein, healthy 
omega-3 fats (called docosahexaenoic acid and eicosapentaenoic acid), 
more vitamin B12 and vitamin D than any other type of food, iron, and 
other minerals like selenium, zinc, and iodine.
    Finally, the revised advice continues to provide information to 
help women who are or might become pregnant, breastfeeding mothers, and 
parents of children over 2 years choose varieties of fish that are 
lower in mercury.
    You may submit comments on the advice at any time.

III. Consolidated Appropriations Act, 2019

    The fish advice provides information for use by consumers. It is 
not intended to have the force and effect of law, does not implement, 
interpret, or prescribe law or policy, and does not describe procedural 
or practice requirements. As required by section 773 of Public Law 116-
6, the revised advice was reviewed by the Office of Management and 
Budget under Executive Order 12866.
    The advice was revised in accordance with the directive in section 
773 of Public Law 116-6 that the advice be updated ``in a manner that 
is consistent with nutrition science recognized by FDA on the net 
effects of seafood consumption.'' FDA considered the totality of the 
evidence, including nutrition science on the net effects of seafood 
consumption, when updating the fish advice. The overall changes we made 
include clarifying the target audience to make clear it applies to 
women who could become or are pregnant, women who are breastfeeding, 
and parents who are feeding children 2 years and older and adding 
highlights of key consumer messages, including that eating fish can 
provide health benefits when pregnant or breastfeeding, that many types 
of fish are both nutritious and lower in mercury, and that the 
consumption advice is based on mercury levels. Specifically, with 
respect to health benefits, the advice now highlights benefits related 
to risk of heart disease and obesity, benefits supporting children's 
growth and development, and the substantive nutritional contributions 
to a healthy diet from protein, omega-3 fats, vitamin B12, vitamin D, 
iron, selenium, zinc, and iodine.
    The primary focus of the revisions is to further align the advice 
with the 2015-2020 Dietary Guidelines for Americans, which establishes 
Federal, evidence-based policy on diet and health. The revised advice 
supports the

[[Page 32749]]

recommendations of the 2015-2020 Dietary Guidelines for Americans, 
developed for people 2 years and older, which reflects current science 
on nutrition to improve public health. The Dietary Guidelines for 
Americans focuses on dietary patterns and the effects of food and 
nutrient characteristics on health. FDA recognizes the nutrition 
science that is reflected in the guidelines, including nutrition 
science that was based on scientific analysis that considered evidence 
regarding the net effects of seafood consumption. In addition, the 
guidelines recommend eating fish as part of a healthy eating pattern 
because there are benefits in doing so.
    The process to develop the 2020-2025 Dietary Guidelines is under 
way, and per the Agricultural Act of 2014, will include a comprehensive 
review of scientific evidence and development of guidance for infants 
and toddlers from birth to 24 months, as well as for women who are 
pregnant. Additionally, EPA is in the process of updating its 
Integrated Risk Information System (IRIS) Assessment for Methylmercury. 
FDA will consider the final products from these efforts, as 
appropriate, in any future updates to the fish advice.

IV. Request for Comments

    FDA intends to develop educational materials such as simple 
factsheets, posters, infographics, and social media tool-kits on the 
updated fish advice for women who are or might become pregnant, 
breastfeeding mothers, and parents of young children. Specific 
materials will also be developed for health care professionals, health 
educators, nutritionists, and dietitians. These resources will be 
printable and could be used in physician's offices, public health 
clinics, and stores.
    FDA is seeking public comment on:
    (1) Additional target populations that should be considered who may 
benefit from this advice;
    (2) Additional information that should be included in these 
educational resources; and
    (3) Additional effective means of disseminating and broadening the 
reach of this information.
    While FDA welcomes comment at any time, we would appreciate 
comments on these questions by September 9, 2019.

V. Electronic Access

    Persons with access to the internet may obtain the advice at either 
https://www.fda.gov/food/resources-you-food, or https://www.regulations.gov. Use the FDA website listed in the previous 
sentence to find the most current version of the advice.

    Dated: July 2, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-14524 Filed 7-8-19; 8:45 am]
 BILLING CODE 4164-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.